Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma

被引:57
作者
Doyle, S
O'Brien, P
Murphy, K
Fleming, C
O'Donnell, J
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Haematol, London W12 0NN, England
[2] St Vincents Univ Hosp, Dept Haematol, Dublin, Ireland
关键词
solvent; detergent plasma; factor V; factor VIII;
D O I
10.1097/01.mbc.0000061298.28953.7d
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Solvent/detergent (S/D) plasma is being increasingly widely used in clinical practice, as it carries significantly lower risk of lipid-enveloped viral transmission than standard fresh frozen plasma (FFP). However, previous reports have suggested that S/D processing might influence the coagulation factor content of plasma. We have investigated this question by measuring procoagulant factors (fibrinogen, factor V and factor VIII), anticoagulant factors (protein C and protein S) and routine coagulation screening tests (prothrombin time and activated partial thromboplastin time) in 48 single-donor units of FFP, and in 16 units of S/D plasma (Octaplas). All routine coagulation screening tests, factor VII and protein C levels were within the normal reference range for both S/D plasma and FFP. However, we found significant reductions in factor V (31%), factor VIII (28%) and protein S (50%) in S/D plasma. The observed quantitative differences in coagulation factor levels may be further exacerbated by the lower volume of solvent detergent plasma units (200 ml) compared with units of standard fresh frozen plasma (250 ml). These findings are of potential clinical significance, particularly in those patients with liver disease, constitutional factor V deficiency and congenital or acquired protein S deficiency. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:283 / 287
页数:5
相关论文
共 23 条
[1]   In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma [J].
Beeck, H ;
Hellstern, P .
VOX SANGUINIS, 1998, 74 :219-223
[2]  
BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P551
[3]   Solvent/detergent treatment of human plasma -: A very robust method for virus inactivation.: Validated virus safety of OCTAPLAS® [J].
Blesert, L ;
Suhartono, H .
VOX SANGUINIS, 1998, 74 :207-212
[4]   Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP®) [J].
de Jonge, J ;
Groenland, THN ;
Metselaar, HJ ;
Ijzermans, JNM ;
van Vliet, HHDM ;
Visser, L ;
Tilanus, HW .
ANESTHESIA AND ANALGESIA, 2002, 94 (05) :1127-1131
[5]   Solvent detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura [J].
Evans, G ;
Llewelyn, C ;
Luddington, R ;
Baglin, TP ;
Williamson, LM .
CLINICAL AND LABORATORY HAEMATOLOGY, 1999, 21 (02) :119-123
[6]  
Flamholz R, 2000, J CLIN APHERESIS, V15, P169, DOI 10.1002/1098-1101(2000)15:3<169::AID-JCA2>3.0.CO
[7]  
2-R
[8]   A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation [J].
Freeman, JW ;
Williamson, LM ;
Llewelyn, C ;
Fisher, N ;
Allain, JP ;
Bellamy, M ;
Baglin, TP ;
Klinc, J ;
Ala, FA ;
Smith, N ;
Neuberger, J ;
Wreghitt, T .
VOX SANGUINIS, 1998, 74 :225-229
[9]  
GILL JC, 1987, BLOOD, V69, P1691
[10]   Plasma exchange with solvent/detergent-treated plasma of resistant thrombotic thrombocytopenic purpura [J].
Harrison, CN ;
Lawrie, AS ;
Iqbal, A ;
Hunter, A ;
Machin, SJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (04) :756-758